Walgreens and Ferring To Provide Fertility Medications to Cancer Patients

In honor of National Ovarian Cancer Month and Gynecologic Cancer Month, both taking place in September, Walgreens and Ferring Pharmaceuticals Inc. today announced a collaboration to provide free access to certain fertility medications and educational resources as part of Ferring's h.e.a.r.t. BEAT program. The program is a patient assistance initiative funded by Ferring and provided as a public service to eligible women of reproductive age who have received a new cancer diagnosis and wish to undergo fertility preservation prior to the start of their cancer treatment.

There are no financial requirements or applications to complete.  Patients must be:

  • Female
  • U.S. citizen or permanent resident
  • Diagnosis of cancer
  • Cancer treatment has not been initiated
  • No recent chemotherapy treatment within prior six months
  • Oncologist and Reproductive Endocrinologist determine that Fertility Preservation treatment is medically appropriate

The fertility medications, manufactured by Ferring Pharmaceuticals Inc., included in the h.e.a.r.t. BEAT progam are BRAVELLE®, MENOPUR®   and NOVAREL®.  Physicians may call Walgreens Specialty Pharmacy at 888-347-3415 with a verbal prescription and the medication will be shipped via UPS to either the physician's office or the patient.  No completion of forms is required. 

Read the Press Release